| 摘要 |
FIELD: medicine, pharmacy. ^ SUBSTANCE: invention relates to a pharmaceutical composition possessing capacity to release the therapeutically effective dose of active substance rivastigmin and showing the time-controlled pattern. The pharmaceutical composition is designated for treatment of patients suffering with Alzheimer's diseases dementia from small to middle severity degree. Compositions show safety and time-controlled release pattern of active substance rivastigmin. ^ EFFECT: valuable medicinal and pharmaceutical properties of composition. ^ 5 cl, 2 tbl, 7 ex |
